Redwire boosts space-based pharma tech with new crystallizer and gold nanoparticle check
by Clarence Oxford
Los Angeles CA (SPX) Apr 23, 2025
Redwire Company (NYSE: RDW), a distinguished power in house infrastructure innovation, has expanded its pharmaceutical analysis efforts in orbit with the deployment of latest crystallization expertise and a groundbreaking cancer-detection experiment aboard the Worldwide Area Station (ISS).
Constructing on the success of its PIL-BOX platform, Redwire has launched a high-volume Industrial Crystallizer designed to course of samples as much as 200 occasions bigger than these beforehand accommodated. This development helps the corporate’s imaginative and prescient of scaling in-space drug growth into commercially viable manufacturing. The purpose is to transform microgravity-based insights into manufacturable supplies that serve terrestrial medical and industrial markets.
A key element of the growth is the “Golden Balls” experiment, which goals to create gold nanospheres in microgravity for the primary time. These nanoparticles have potential makes use of in medical diagnostics and focused most cancers therapies. Redwire expects space-grown nanospheres to exhibit enhanced dimension uniformity and floor integrity, attributes that might enhance their effectiveness in biomedical functions.
“Gold nanospheres may result in early testing and prognosis of most cancers and different ailments, focused drug supply, and enhanced radiation and photothermal remedy, providing a promising strategy to most cancers administration,” stated John Vellinger, Redwire’s President of In-Area Industries.
The brand new Industrial Crystallizer and the Golden Balls experiment have been launched aboard SpaceX’s thirty second business resupply mission to the ISS on April twenty first.
Associated Hyperlinks
